Annual report pursuant to Section 13 and 15(d)

Stock-Based Compensation - Liberty - Outstanding Awards (Details)

v3.20.4
Stock-Based Compensation - Liberty - Outstanding Awards (Details) - USD ($)
$ / shares in Units, $ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Additional disclosures      
Total unrecognized compensation cost related to unvested equity awards $ 56    
Weighted average period of recognition related to unvested equity awards (in years) 2 years    
Options, exercises in period, total intrinsic value $ 8 $ 163 $ 22
Common Class B      
Number of options      
Outstanding at end of period 0    
Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, vested in period, fair value $ 45 $ 17 $ 9
Liberty SiriusXM Group      
Additional disclosures      
Common stock reserved for issuance 10,900,000    
Liberty SiriusXM Group | Common Class C      
Number of options      
Outstanding at beginning of period 9,817,000    
Granted 1,425,000    
Exercised (372,000)    
Outstanding at end of period 10,870,000 9,817,000  
Exercisable at end of period 8,705,000    
WAEP      
Outstanding at beginning of period $ 33.90    
Granted 41.26    
Exercised 31.10    
Outstanding at end of period 34.96 $ 33.90  
Exercisable at end of period $ 32.62    
Additional disclosures      
Weighted average remaining life, outstanding 3 years 2 months 12 days    
Weighted average remaining life, exercisable 2 years 4 months 24 days    
Aggregate intrinsic value, outstanding $ 97    
Aggregate intrinsic value, exercisable $ 95    
Liberty SiriusXM Group | Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, nonvested, number 77,000    
Restricted stock weighted average grant-date fair value $ 35.81    
Formula One Group      
Additional disclosures      
Common stock reserved for issuance 10,400,000    
Formula One Group | Common Class C      
Number of options      
Outstanding at beginning of period 8,284,000    
Granted 2,531,000    
Exercised (424,000)    
Outstanding at end of period 10,391,000 8,284,000  
Exercisable at end of period 8,113,000    
WAEP      
Outstanding at beginning of period $ 31.16    
Granted 33.35    
Exercised 29.06    
Outstanding at end of period 31.78 $ 31.16  
Exercisable at end of period $ 29.84    
Additional disclosures      
Weighted average remaining life, outstanding 4 years 6 months    
Weighted average remaining life, exercisable 4 years    
Aggregate intrinsic value, outstanding $ 114    
Aggregate intrinsic value, exercisable $ 104    
Formula One Group | Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, nonvested, number 76,000    
Restricted stock weighted average grant-date fair value $ 32.81    
Braves Group      
Additional disclosures      
Common stock reserved for issuance 3,500,000    
Braves Group | Common Class C      
Number of options      
Outstanding at beginning of period 1,267,000    
Granted 2,220,000    
Exercised (12,000)    
Outstanding at end of period 3,475,000 1,267,000  
Exercisable at end of period 1,012,000    
WAEP      
Outstanding at beginning of period $ 21.82    
Granted 26.48    
Exercised 17.10    
Outstanding at end of period 24.81 $ 21.82  
Exercisable at end of period $ 19.02    
Additional disclosures      
Weighted average remaining life, outstanding 5 years 7 months 6 days    
Weighted average remaining life, exercisable 2 years 8 months 12 days    
Aggregate intrinsic value, outstanding $ 6    
Aggregate intrinsic value, exercisable $ 6    
Braves Group | Restricted Stock and Restricted Stock Units      
Additional disclosures      
Equity instruments other than options, nonvested, number 204,000    
Restricted stock weighted average grant-date fair value $ 25.75